PROBING THE ACTIVE SITE OF THE MITOCHONDRIAL HOLOCYTOCHROME C SYNTHASE, HCCS
探测线粒体全细胞色素 C 合成酶 (HCCS) 的活性位点
基本信息
- 批准号:9279705
- 负责人:
- 金额:$ 2.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2016-10-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAffectAmino AcidsAmoeba genusAnimalsApoptosisBindingBinding SitesBiochemicalBioenergeticsBiogenesisBiological AssayBiological ProcessCell RespirationCellsCellular biologyCessation of lifeChemicalsComplexCysteineCytochrome c GroupCytochromesDataDefectDiseaseElectronsEnvironmentEscherichia coliEukaryotaEukaryotic CellFigs - dietaryHealthHemeHistidineHomologous GeneHumanHuman ActivitiesIn VitroKnowledgeLabelLengthLifeMass Spectrum AnalysisMediatingMetalloproteinsMethodsMitochondriaModificationMutationOrganellesPathway interactionsPeptidesPlayPositioning AttributeProcessProductionProkaryotic CellsPropertyProsthesisProteinsProtocols documentationRecombinantsRoleSiteSite-Directed MutagenesisStructureSystemTestingWorkYeastsabsorptionbasecofactorcrosslinkcytochrome C synthetasecytochrome cheme ahuman diseasein vivoinsightmicrophthalmia-dermal aplasia-sclerocornea syndromemutantthioether
项目摘要
DESCRIPTION (provided by applicant): In eukaryotes, cytochrome c plays a vital role in both aerobic respiration and apoptosis, thus impacting the life and death of a cell. C-type cytochromes are characterized by covalent attachment of a heme co-factor, a modification that is required for its stability and subsequent function. Heme attachment takes place in the mitochondria and is mediated by holocytochrome c synthase, HCCS, the primary component of the eukaryotic cytochrome c biogenesis pathway, also known as System III.
Previous studies in animals have shown that defects in HCCS can result in lethality or the human disease microphthalmia with linear skin defects (MLS). Although HCCS was discovered in yeast 25 years ago, the mechanisms underlying HCCS function have yet to be explored, largely due to its poor recombinant expression and instability. Our lab has very recently been successful in overcoming these technical limitations, allowing us to initiate the first comprehensive biochemical analysis of HCCS structure/ function.
The catalytic function of HCCS depends on its ability to interact with and coordinate interactions between its substrates, heme and cytochrome c. Therefore, the proposed study seeks to determine which residues and/or domains in HCCS comprise its active site. Aim 1 analyzes the functional consequences of mutations of highly conserved residues in HCCS by examining perturbations in heme binding and cytochrome c recruitment and maturation. The apocytochrome c substrate-binding site of HCCS is directly assessed in Aim 2 by peptide crosslinking, using a UV-crosslinkable cytochrome c peptide containing the heme-attachment site.
These studies will provide the first in-depth mechanistic analysis of HCCS, thus advancing our understanding of mitochondrial bioenergetics. Our results will directly impact what is currently known about diseases like MLS that are caused by HCCS abnormalities, as well as contribute to the body of knowledge concerning the many malfunctions observed in mitochondria in other human conditions.
描述(申请人提供):在真核生物中,细胞色素c在有氧呼吸和细胞凋亡中发挥着至关重要的作用,从而影响细胞的生死。 C 型细胞色素的特点是共价连接血红素辅助因子,这是其稳定性和后续功能所必需的修饰。血红素附着发生在线粒体中,由全细胞色素 c 合酶 HCCS 介导,HCCS 是真核细胞色素 c 生物发生途径(也称为系统 III)的主要组成部分。
此前对动物的研究表明,HCCS 缺陷可导致死亡或伴有线性皮肤缺陷 (MLS) 的人类疾病小眼症。尽管 HCCS 于 25 年前在酵母中被发现,但 HCCS 功能的机制尚未被探索,这主要是由于其重组表达较差且不稳定。我们的实验室最近成功克服了这些技术限制,使我们能够对 HCCS 结构/功能进行首次全面的生化分析。
HCCS 的催化功能取决于其与其底物血红素和细胞色素 c 相互作用并协调它们之间相互作用的能力。因此,拟议的研究旨在确定 HCCS 中的哪些残基和/或结构域构成其活性位点。目标 1 通过检查血红素结合以及细胞色素 c 募集和成熟的扰动来分析 HCCS 中高度保守残基突变的功能后果。在目标 2 中,使用含有血红素附着位点的可 UV 交联的细胞色素 c 肽,通过肽交联直接评估 HCCS 的脱辅基细胞色素 c 底物结合位点。
这些研究将首次对 HCCS 进行深入的机制分析,从而增进我们对线粒体生物能学的理解。我们的结果将直接影响目前对由 HCCS 异常引起的 MLS 等疾病的了解,并有助于了解其他人类疾病中线粒体中观察到的许多功能障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shalon Elizabeth Ledbetter其他文献
The Unconventional Amino Acid Starvation Response of the Malaria Parasite, Plasmodium falciparum
疟原虫恶性疟原虫的非常规氨基酸饥饿反应
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Shalon Elizabeth Ledbetter - 通讯作者:
Shalon Elizabeth Ledbetter
Shalon Elizabeth Ledbetter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shalon Elizabeth Ledbetter', 18)}}的其他基金
PROBING THE ACTIVE SITE OF THE MITOCHONDRIAL HOLOCYTOCHROME C SYNTHASE, HCCS
探测线粒体全细胞色素 C 合成酶 (HCCS) 的活性位点
- 批准号:
8717157 - 财政年份:2014
- 资助金额:
$ 2.9万 - 项目类别:
相似国自然基金
低蛋白日粮脂肪和蛋白质互作影响氨基酸消化率的机制
- 批准号:32302793
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
孕期母体支链氨基酸代谢紊乱和子代支链氨基酸代谢酶基因遗传变异联合作用对儿童神经行为发育影响的队列研究
- 批准号:82373581
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
影响植物磷砷选择性吸收关键氨基酸位点的挖掘及分子机制研究
- 批准号:42307009
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氨基酸多态性对代谢生成亚硝(酰)胺前体物的影响机理研究
- 批准号:22376114
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
3型鸭甲型肝炎病毒2C蛋白氨基酸位点变异对病毒致病性的影响及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models
从高分辨率分子动力学和序列共变模型推断出 HIV 适应性和耐药性的机制
- 批准号:
10750627 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Actions of spiropyrimidinetriones against bacterial type II topoisomerases
螺嘧啶三酮对细菌 II 型拓扑异构酶的作用
- 批准号:
10750473 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:
10599654 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Investigating the oxidative chemistry and electron transfer in polysaccharide monooxygenases
研究多糖单加氧酶的氧化化学和电子转移
- 批准号:
10464734 - 财政年份:2022
- 资助金额:
$ 2.9万 - 项目类别:
Development of Modified Caveolin-1 Scaffolding Domain Peptides with Improved Pharmacological Properties as Therapeutic Agents for Scleroderma Skin Disease
开发具有改善药理特性的修饰的 Caveolin-1 支架结构域肽作为硬皮病皮肤病的治疗剂
- 批准号:
10544238 - 财政年份:2022
- 资助金额:
$ 2.9万 - 项目类别: